Immunodominant regions prediction of nucleocapsid protein for SARS-CoV-2 early diagnosis: a bioinformatics and immunoinformatics study. (16th November 2020)

• Record Type: Journal Article
• Authors: Dai, Yufeng; Chen, Hongzhi; Zhuang, Siqi; Feng, Xiaojing; Fang, Yiyuan; Tang, Haoneng; Dai, Ruchun; Tang, Lingli; Liu, Jun; Ma, Tianmin; Zhong, Guangming
• Is Part Of: Pathogens and global health. Volume 114:Number 8(2020)
• Page Start: 463
• Page End: 470
• Publication Date: 2020-11-16
• Subjects: SARS-CoV-2 -- COVID-19 -- linear B-cell epitopes -- nucleocapsid protein -- antigen-capture diagnostics; Communicable diseases -- Periodicals; Public health -- International cooperation -- Periodicals; World health -- Periodicals; 362.1969
• DOI: 10.1080/20477724.2020.1838190
• Languages: English
• ISSNs: 2047-7724

Abstract

ABSTRACT: COVID-19 caused by SARS-CoV-2 is sweeping the world and posing serious health problems. Rapid and accurate detection along with timely isolation is the key to control the epidemic. Nucleic acid test and antibody-detection have been applied in the diagnosis of COVID-19, while both have their limitations. Comparatively, direct detection of viral antigens in clinical specimens is highly valuable for the early diagnosis of SARS-CoV-2. The nucleocapsid (N) protein is one of the predominantly expressed proteins with high immunogenicity during the early stages of infection. Here, we applied multiple bioinformatics servers to forecast the potential immunodominant regions derived from the N protein of SARS-CoV-2. Since the high homology of N protein between SARS-CoV-2 and SARS-CoV, we attempted to leverage existing SARS-CoV immunological studies to develop SARS-CoV-2 diagnostic antibodies. Finally, N229-269, N349-399, and N405-419 were predicted to be the potential immunodominant regions, which contain both predicted linear B-cell epitopes and murine MHC class II binding epitopes. These three regions exhibited good surface accessibility and hydrophilicity. All were forecasted to be non-allergen and non-toxic. The final construct was built based on the bioinformatics analysis, which could help to develop an antigen-capture system for the early diagnosis of SARS-CoV-2.